BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 16644201)

  • 21. The role of vascular endothelial growth factors and their receptors in malignant melanomas.
    Brychtova S; Bezdekova M; Brychta T; Tichy M
    Neoplasma; 2008; 55(4):273-9. PubMed ID: 18505336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of CCR10/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives.
    Mergia Terefe E; Catalan Opulencia MJ; Rakhshani A; Ansari MJ; Sergeevna SE; Awadh SA; Polatova DS; Abdulkadhim AH; Mustafa YF; Kzar HH; Al-Gazally ME; Kadhim MM; Taherian G
    Expert Rev Mol Med; 2022 Sep; 24():e37. PubMed ID: 36155126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiles of chemokine receptors in melanocytic lesions: de novo expression of CXCR6 in melanoma.
    Seidl H; Richtig E; Tilz H; Stefan M; Schmidbauer U; Asslaber M; Zatloukal K; Herlyn M; Schaider H
    Hum Pathol; 2007 May; 38(5):768-80. PubMed ID: 17306330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
    Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
    Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas.
    Sarff M; Edwards D; Dhungel B; Wegmann KW; Corless C; Weinberg AD; Vetto JT
    Am J Surg; 2008 May; 195(5):621-5; discussion 625. PubMed ID: 18374895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High CCL27 immunoreactivity in 'supratumoral' epidermis correlates with better prognosis in patients with cutaneous malignant melanoma.
    Martinez-Rodriguez M; Thompson AK; Monteagudo C
    J Clin Pathol; 2017 Jan; 70(1):15-19. PubMed ID: 27325798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCL27-transgenic mice show enhanced contact hypersensitivity to Th2, but not Th1 stimuli.
    Kagami S; Saeki H; Tsunemi Y; Nakamura K; Kuwano Y; Komine M; Nakayama T; Yoshie O; Tamaki K
    Eur J Immunol; 2008 Mar; 38(3):647-57. PubMed ID: 18266301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.
    Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Stramazzotti D; Morichetti D; Bernardini ML; Mannello B; Fabris G; Offidani A
    Br J Dermatol; 2007 Dec; 157(6):1155-60. PubMed ID: 17916208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCL28 production in HaCaT cells was mediated by different signal pathways from CCL27.
    Kagami S; Saeki H; Komine M; Kakinuma T; Nakamura K; Tsunemi Y; Sasaki K; Asahina A; Tamaki K
    Exp Dermatol; 2006 Feb; 15(2):95-100. PubMed ID: 16433680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking.
    Soler D; Humphreys TL; Spinola SM; Campbell JJ
    Blood; 2003 Mar; 101(5):1677-82. PubMed ID: 12406880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
    Richardson SK; Newton SB; Bach TL; Budgin JB; Benoit BM; Lin JH; Yoon JS; Wysocka M; Abrams CS; Rook AH
    Am J Hematol; 2007 Sep; 82(9):792-7. PubMed ID: 17546636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cotransduction of CCL27 gene can improve the efficacy and safety of IL-12 gene therapy for cancer.
    Gao JQ; Kanagawa N; Motomura Y; Yanagawa T; Sugita T; Hatanaka Y; Tani Y; Mizuguchi H; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    Gene Ther; 2007 Mar; 14(6):491-502. PubMed ID: 17203106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.
    Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R
    J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune evasion by murine melanoma mediated through CC chemokine receptor-10.
    Murakami T; Cardones AR; Finkelstein SE; Restifo NP; Klaunberg BA; Nestle FO; Castillo SS; Dennis PA; Hwang ST
    J Exp Med; 2003 Nov; 198(9):1337-47. PubMed ID: 14581607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TNF family molecule LIGHT regulates chemokine CCL27 expression on mouse embryonic stem cell-derived dendritic cells through NF-kappaB activation.
    Zou GM; Hu WY; Wu W
    Cell Signal; 2007 Jan; 19(1):87-92. PubMed ID: 16978841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CCL27/CCL28-CCR10 Chemokine Signaling Mediates Migration of Lymphatic Endothelial Cells.
    Karnezis T; Farnsworth RH; Harris NC; Williams SP; Caesar C; Byrne DJ; Herle P; Macheda ML; Shayan R; Zhang YF; Yazar S; Takouridis SJ; Gerard C; Fox SB; Achen MG; Stacker SA
    Cancer Res; 2019 Apr; 79(7):1558-1572. PubMed ID: 30709930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression.
    Einspahr JG; Thomas TL; Saboda K; Nickolof BJ; Warneke J; Curiel-Lewandrowski C; Ranger-Moore J; Duckett L; Bangert J; Fruehauf JP; Alberts DS
    Cancer; 2007 Dec; 110(11):2519-27. PubMed ID: 17932890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of p16 and p27 is correlated with tumour progression in cutaneous melanoma.
    Sanki A; Li W; Colman M; Karim RZ; Thompson JF; Scolyer RA
    Pathology; 2007 Dec; 39(6):551-7. PubMed ID: 18027257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.